View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
HHS/FDA | RIN: 0910-AI93 | Publication ID: Spring 2024 |
Title: ●Radiology Devices; Classification of Blood Irradiator Devices | |
Abstract:
FDA is proposing to classify two types of blood irradiators, which are unclassified preamendments devices, based on intended use. Specifically, FDA is proposing to classify blood irradiators intended for the prevention of transfusion-associated graft versus host disease into Class II and blood irradiators intended for prevention of metastasis by irradiating intra-operatively salvaged blood of cancer patients undergoing surgery into Class III. |
|
Agency: Department of Health and Human Services(HHS) | Priority: Substantive, Nonsignificant |
RIN Status: First time published in the Unified Agenda | Agenda Stage of Rulemaking: Proposed Rule Stage |
Major: No | Unfunded Mandates: No |
CFR Citation: 21 CFR 892.7000 | |
Legal Authority: 21 U.S.C. 351 21 U.S.C. 360 21 U.S.C. 360c 21 U.S.C. 360e 21 U.S.C. 360j 21 U.S.C. 360l 21 U.S.C. 371 |
Legal Deadline:
None |
||||||
Timetable:
|
Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
Small Entities Affected: No | Federalism: No |
Included in the Regulatory Plan: No | |
RIN Data Printed in the FR: No | |
Agency Contact: Patricia Kaufman Regulatory Counsel Department of Health and Human Services Food and Drug Administration 10903 New Hampshire Avenue, WO 66, Silver Spring, MD 20993 Phone:301 796-1174 Email: patricia.kaufman@fda.hhs.gov |